Meanwhile, the sensitive and LLL12 treated cells were enriched in the NFkB, PI3-Akt, TNF, and JAK-STAT signaling pathway known to be essential for CML maintenance (Fig. 3E) [3]. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.